PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIOTHERAPY IN ADULTS WITH NEWLY-DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA

被引：0
|
作者：
Majd, Nazanin [1 ]
Liu, John [2 ]
Yeboa, Nana [1 ]
Wang, Shuqi [1 ]
Weathers, Shiao-Pei [1 ]
Yuan, Ying [1 ]
Gachimova, Evguenia [1 ]
Wathoo, Chetna [1 ]
Kamiya-Matsuoka, Carlos [1 ]
O'Brien, Barbara [1 ]
Aaroe, Ashley [1 ]
Patel, Chirag [1 ]
Patel, Anuj [1 ]
Dagher, Samir [1 ]
Wintermark, Max [1 ]
Ferguson, Sherise [1 ]
Puduvalli, Vinay [1 ]
Raleigh, David [2 ]
de Groot, John [2 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Calif San Francisco, San Francisco, CA USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.0461
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DNAR-10
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
    Sim, Hao-Wen
    McDonald, Kerrie L.
    Lwin, Zarnie
    Barnes, Elizabeth H.
    Rosenthal, Mark
    Foote, Matthew C.
    Koh, Eng-Siew
    Back, Michael
    Wheeler, Helen
    Sulman, Erik P.
    Buckland, Michael E.
    Fisher, Lauren
    Leonard, Robyn
    Hall, Merryn
    Ashley, David M.
    Yip, Sonia
    Simes, John
    Khasraw, Mustafa
    NEURO-ONCOLOGY, 2021, 23 (10) : 1736 - 1749
  • [42] A NIRAPARIB EFFICACY IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: CLINICAL READOUT OF A PHASE 0/2 'TRIGGER' TRIAL
    Sanai, N.
    Umemura, Y.
    Margaryan, T.
    Molloy, J.
    Zhang, H.
    Knight, W.
    Harmon, J.
    Hong, A.
    Wanebo, J.
    Braun, K.
    Kennedy, W.
    Garcia, M.
    Barani, I.
    Yoo, W.
    Tien, A.
    Tovmasyan, A.
    Mehta, S.
    NEURO-ONCOLOGY, 2024, 26
  • [43] CC-115 IN NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II RANDOMIZED BAYESIAN ADAPTIVE PLATFORM TRIAL
    Rahman, Rifaquat
    Trippa, Lorenzo
    Fell, Geoffrey
    Lee, Eudocia
    Arrillaga-Romany, Isabel
    Touat, Mehdi
    McCluskey, Christine
    Brunno, Jennifer
    Gaffey, Sarah
    Drappatz, Jan
    Lassman, Andrew
    Galanis, Evanthia
    Ahluwalia, Manmeet
    Colman, Howard
    Nabors, Louis
    Hepel, Jaroslaw
    Elinzano, Heinrich
    Schiff, David
    Chukwueke, Ugonma
    Beroukhim, Rameen
    Nayak, Lakshmi
    Mcfaline-Figueroa, Jose
    Batchelor, Tracy
    Rinne, Mikael
    Kaley, Thomas
    Lu-Emerson, Christine
    Bi, Wenya Linda
    Arnaout, Omar
    Haas-Kogan, Daphne
    Tanguturi, Shyam
    Cagney, Daniel
    Aizer, Ayal A.
    Welch, Mary
    Doherty, Lisa
    Lavallee, Maria
    Fisher-Longden, Brittany
    Dowling, Shanna
    Geduldig, Jack
    Watkinson, Fiona
    Santagata, Sandro
    Meredith, David
    Chiocca, E. Antonio
    Reardon, David
    Ligon, Keith
    Alexander, Brian
    Wen, Patrick
    NEURO-ONCOLOGY, 2020, 22 : 43 - 44
  • [44] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Pierscianek, Daniela
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2021, 23 : 68 - 68
  • [45] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, S.
    Pierscianek, D.
    Proescholdt, M.
    Hau, P.
    Grosu, A.
    Krex, D.
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    NEURO-ONCOLOGY, 2021, 23 : 50 - 50
  • [46] PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma
    Kebir, S.
    Lazaridis, L.
    Schmidt, T.
    Oster, C.
    Pierscianek, D.
    Guberina, N.
    Kleinschnitz, C.
    Proescholdt, M.
    Hau, P.
    Grosu, A. -L
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S74 - S74
  • [47] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Pierscianek, Daniela
    Guberina, Nika
    Kleinschnitz, Christoph
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2020, 22 : 61 - 61
  • [48] Results of PARADIGM-2: a phase I study of olaparib-radiotherapy in MGMT unmethylated glioblastoma
    Derby, Sarah J.
    Jackson, Mark R.
    Sweeting, Lorna Sweeting
    Shad, Shumaila
    Paterson, Lucy
    Stobo, Jamie
    Nowicki, Stefan
    Williamson, Aoife
    Bulbeck, Helen
    Short, Susan C.
    McBain, Catherine
    Herbert, Christopher
    Powell, James
    Kelly, Caroline
    Chalmers, Anthony J.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S876 - S879
  • [49] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Saran, Frank
    Welsh, Liam
    James, Allan
    McBain, Catherine
    Gattamaneni, Rao
    Jefferies, Sarah
    Harris, Fiona
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Cseh, Agnieszka
    Brada, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 307 - 317
  • [50] Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma
    Holdhoff, Matthias
    Ye, Xiaobu
    Strowd, Roy E.
    Nabors, Burt
    Walbert, Tobias
    Lieberman, Frank S.
    Bagley, Stephen J.
    Fiveash, John B.
    Fisher, Joy D.
    Desideri, Serena
    Surakus, Trisha
    Engelhardt, Marc
    Kaindl, Thomas
    Lane, Heidi A.
    Litherland, Karine
    Grossman, Stuart A.
    Kleinberg, Lawrence R.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
12345